Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-01 @ 4:07 PM
Study NCT ID:
NCT05193604
Status:
TERMINATED
Last Update Posted:
2023-12-08
First Post:
2021-12-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-27
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-28
First Submit QC Date:
None
Study First Post Date:
2022-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-03
Last Update Post Date:
2023-12-08
Last Update Post Date Type:
ACTUAL